Exploring Efficacy And Safety Of Immune Checkpoint Inhibitors (Ici) In Extensive Stage (Es)- Small-Cell Lung Cancer (Sclc) In Specific Populations: Real-World Data From The Durvalumab Expanded Access Program Regional European Cohort (Dear)
Durvalumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Exploring Efficacy And Safety Of Immune Checkpoint Inhibitors (Ici) In Extensive Stage (Es)- Small-Cell Lung Cancer (Sclc) In Specific Populations: Real-World Data From The Durvalumab Expanded Access Program Regional European Cohort (Dear) ### Output: Durvalumab